Sign inGet started

Lewis Hayley

Insider CIK 1631295 · CBYL See Remarks · ZSAN VP, Reg Affairs & Quality

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZSAN Zosano Pharma Corp S Sale2021-06-042021-06-071,709$0.81 $1.4K49,779SEC↗
ZSAN Zosano Pharma Corp A Award deriv2021-03-302021-04-0165,000— $065,000SEC↗
ZSAN Zosano Pharma Corp A Award2021-03-302021-04-0132,500— $051,488SEC↗
ZSAN Zosano Pharma Corp A Award2020-06-252020-06-2918,750— $018,988SEC↗
ZSAN Zosano Pharma Corp A Award deriv2020-06-032020-06-0537,500— $037,500SEC↗
ZSAN Zosano Pharma Corp A Award deriv2019-06-112019-06-1330,000— $030,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2019-06-112019-06-1930,000— $030,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2018-05-312018-06-01100,000— $0100,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2017-05-312018-04-27180,000— $0180,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2017-04-102017-04-1215,000— $015,000SEC↗
ZSAN Zosano Pharma Corp P Buy deriv2016-08-192016-08-224,775$0.13 $6214,775SEC↗
ZSAN Zosano Pharma Corp P Buy deriv2016-08-192016-08-224,775$0.13 $6214,775SEC↗
ZSAN Zosano Pharma Corp P Buy2016-08-192016-08-224,775$1.32 $6.3K4,775SEC↗
CBYL Carbylan Therapeutics, Inc A Award deriv2015-08-032015-08-0533,181— $033,181SEC↗